Worldwide Medical Robots Industry to 2026 - Increase in Geriatric Population is Driving Growth
Worldwide Medical Robots Industry to 2026 - Increase in Geriatric Population is Driving Growth
DUBLIN, Nov. 1, 2021 /PRNewswire/ -- The "Medical Robots Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering.
都柏林2021年11月1日/美通社/--新增《医疗机器人市场--2021年至2026年预测》报告Research andMarkets.com的献祭。
The medical robot market is projected to grow at a CAGR of 12.21% to reach US$4,984.210 million by 2026, from US$2,225.233 million in 2019. Medical robots make all medical operations simpler, secure, and efficient. These robots are being used to performed surgeries with high precision as the error rate is negligible. Hospitals make use of medical robots worldwide for tasks requiring precision and promptness. The success rate of the surgeries performed by robots is much higher as compared to those by humans, which is the primary reason behind the surge in the demand for medical robots across the globe. Also, increasing the investment in the healthcare sector by the governing bodies of various countries will fuel the market growth during the forecast period.
医疗机器人市场预计将以12.21%的复合年增长率增长,到2026年达到49.842.1亿美元,从22.2523亿美元2019年。医疗机器人使所有的医疗操作变得更简单、安全和高效。这些机器人被用来进行高精度的手术,因为错误率可以忽略不计。医院在全球范围内使用医疗机器人完成需要精确和迅速的任务。与人类相比,机器人进行手术的成功率要高得多,这是全球医疗机器人需求激增的主要原因。此外,各国管理机构增加对医疗保健领域的投资将在预测期内推动市场增长。
According to CMS, 2020, in the United States, health care spending grew 4.6% in 2019, reaching $3.8 trillion or $11,582 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.7%. In addition, in countries like the United States and Europe, robots are used for mixing and measure medicines especially those used in chemotherapy. These are very helpful in avoiding the chances of human error which otherwise can cause deleterious effects. The use of robots for the mixing and measuring of medicines in chemotherapy will propel the market growth as the number of patients suffering from cancer, nationwide are on a surge which will increase the demand for the robots in the next few years. According to the National Cancer Institute, 2020, there will be an estimated 1,806,590 new cases of cancer diagnosed in the United States.
Moreover, the increase in funding for medical robots, technological advancements, and issuing IPOs by the medical robot companies are some of the driving factors driving the growth of the global medical robots market in the forecast period. The key market players have been launching new products, acquiring and merging with competitors, to remain competitive in the market which will further strengthen the market growth. For instance, in October 2019, Stryker Corporation, acquired Wright Medical Group N.V., a global medical device company focused on extremities and biologics to complement their product portfolio. Also, with the adoption of minimally invasive surgeries, the number of invasive surgeries being performed has spiked, which in turn will bolster the demand for surgical robots emanating the market growth in the coming years. According to the NCBI, 2019, at least 230 million invasive procedures were being performed annually, worldwide. Furthermore, the medical robots can be used in several applications such as telepresence, surgical assistants, rehabilitation robots, medical transportation robots, sanitation, and disinfection robots, and many more, which will further contribute to their market growth during the forecast period. For instance, In May 2019, Bionik, a robotics company, completed the training for Robot-Assisted Training for the Upper Limb after Stroke (RATULS) trial by applying to the companies in Motion Robotic Therapy Systems.
Growth Factors
根据CMS的数据,2020年,在美国,医疗保健支出在2019年增长了4.6%,达到3.8万亿美元或每人11582美元。医疗费用占国内生产总值的比重为17.7%。此外,在像这样的国家美国在欧洲,机器人被用来混合和测量药物,特别是那些用于化疗的药物。这些都非常有助于避免人为错误的机会,否则可能会造成有害的影响。在化疗中使用机器人混合和测量药物将推动市场增长,因为全国癌症患者数量激增,这将在未来几年增加对机器人的需求。根据美国国家癌症研究所(National Cancer Institute)的数据,到2020年,估计将有1806590例新的癌症病例被诊断出来。美国.此外,医疗机器人资金的增加、技术进步以及医疗机器人公司的首次公开募股(IPO)是推动全球医疗机器人市场在预测期内增长的一些驱动因素。主要市场参与者一直在推出新产品,收购并与竞争对手合并,以保持市场竞争力,这将进一步加强市场增长。例如,2019年10月,Stryker Corporation收购了Wright Medical Group N.V.,这是一家专注于肢体和生物制剂的全球医疗设备公司,以补充其产品组合。此外,随着微创手术的采用,正在进行的侵入性手术的数量激增,这反过来将提振对手术机器人的需求,从而推动未来几年的市场增长。根据NCBI的数据,2019年,全球每年至少进行2.3亿例侵入性手术。此外,医疗机器人可用于临场感、手术助手、康复机器人、医疗运输机器人、卫生和消毒机器人等多个应用,这将进一步促进其在预测期内的市场增长。例如,在2019年5月,Bionik是一家机器人公司,通过申请运动机器人治疗系统公司(Companies In Motion Robotic Treatment Systems),完成了中风后上肢机器人辅助训练(RATULS)试验的培训。生长因子
Increase in the geriatric population
老年人口的增加
The increase in the geriatric population across the globe is expected to drive the market growth of the medical robots market as the population aged above the age of 65 years are more prone to chronic diseases for which they will require precision surgeries, which in turn will accelerate the demand for robots in the market. According to the United Nations, in 2019, the geriatric population was 703 million persons, nationwide. The number of older persons is projected to double to 1.5 billion in 2050, this will fuel the market growth during the forecast period.
Restraints
全球老年人口的增加预计将推动医疗机器人市场的增长,因为65岁以上的人口更容易患上慢性病,他们将需要精密手术,这反过来将加速市场对机器人的需求。根据联合国的数据,2019年,全国老年人口为7.03亿人。预计到2050年,老年人的数量将翻一番,达到15亿,这将在预测期内推动市场增长。约束
High costs
高成本
Robot-assisted surgeries are much costlier than minimally invasive surgeries which may restrain the market growth in the long run as the majority of the population might not be able to afford it. Also, many small hospitals might not adopt this technology as the regularly maintained cost of these robots is very high which they might not be able to afford due to budgetary constraints. The annual maintenance cost of a robot is nearly USD 125,000, which further adds to the existing high cost of robotic surgery. Thus, the high costs associated with the medical robots may hamper the market growth during the forecast period.
COVID-19 Impact On Medical Robots Market
机器人辅助手术比微创手术昂贵得多,从长远来看,这可能会抑制市场增长,因为大多数人可能负担不起。此外,许多小型医院可能不会采用这项技术,因为这些机器人的定期维护成本非常高,由于预算限制,他们可能负担不起。一台机器人每年的维护成本接近12.5万美元,这进一步增加了目前机器人手术的高昂成本。因此,与医疗机器人相关的高昂成本可能会阻碍预测期内的市场增长。新冠肺炎对医疗机器人市场的影响
The Covid-19 pandemic negatively impacted the medical robots market as due to the nationwide lockdown restrictions, many patients deferred their ongoing treatments to avoid public places which hampered the market growth. The pandemic led to a temporary ban on elective surgeries across the globe, which resulted in cancellations of elective surgeries worldwide, which further declined the demand for medical robots in 2020. However, with the ease of restrictions, the ban on surgeries has been lifted owing to which the market is expected to rebound during the forecast period.
Competitive Insights
新冠肺炎疫情对医疗机器人市场产生了负面影响,因为由于全国范围内的封锁限制,许多患者推迟了正在进行的治疗,以避免出现阻碍市场增长的公共场所。这场大流行导致全球暂时禁止选择性手术,导致全球范围内选择性手术被取消,这进一步降低了2020年对医疗机器人的需求。然而,随着限制的放宽,手术禁令已经解除,预计市场将在预测期内反弹。竞争洞察力
The market leaders for the medical robots market consist of Intuitive Surgical, Inc., Stryker Corporation, Hocoma, Medtronic PLC, Auris Health, Inc., Accuray Incorporated, Omnicell, Inc., ARxIUM group of companies, Ekso Bionics Europe GmbH, and Capsa Healthcare, LLC. The key players in the market implement growth strategies such as product launches, mergers, and acquisitions, etc. to gain a competitive advantage over their competitors. For instance, in December 2018, Medtronic PLC, a medical device company, acquired Mazor Robotics, an Israeli medical device company and manufacturer of a robotic guidance system for spine surgery to enhance their medical robotics technology.
医疗机器人市场的领先者包括直觉外科公司公司、斯特莱克公司、霍科姆公司、美敦力公司、奥里斯健康公司、Accuray公司、欧姆尼克公司、ARxIUM集团公司、Ekso仿生欧洲公司和Capsa Healthcare,LLC。市场上的主要参与者实施产品发布、合并和收购等增长战略,以获得相对于竞争对手的竞争优势。例如,2018年12月,医疗器械公司美敦力收购了以色列医疗器械公司Mazor Robotics,该公司是脊柱手术机器人导航系统的制造商,以提升他们的医疗机器人技术。
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.4. Industry Value Chain Analysis
5. Medical Robots Market Analysis, By Product
5.1. Introduction
5.2. Surgical Robotic Systems
5.3. Rehabilitation Robotic Systems
5.4. Pharmacy Robotics Systems
5.5. Non-Invasive Radiosurgery Robotics Systems
6. Medical Robots Market Analysis, By Application
6.1. Introduction
6.2. Laparoscopy
6.3. Neurosurgery
6.4. Dispensing Medicines
6.5. Orthopedics Surgery
6.6. Others
7. Medical Robots Market Analysis, By Geography
8. Competitive Intelligence
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players
9. Company Profiles
9.1. Intuitive Surgical, Inc.
9.2. Stryker Corporation
9.3. Hocoma
9.4. Medtronic PLC
9.5. Auris Health, Inc.
9.6. Accuray Incorporated
9.7. Omnicell, Inc.
9.8. ARxIUM group of companies
9.9. Ekso Bionics Europe GmbH
9.10. Capsa Healthcare, LLC
For more information about this report visit https://www.researchandmarkets.com/r/b84q1j
涵盖的主要主题: 1.引言二、研究方法3.执行摘要4.市场动态4.1.市场驱动因素4.2.市场约束4.3.波特的五力分析4.4.产业价值链分析5.按产品分类的医疗机器人市场分析5.1.引言5.2.外科机器人系统5.3.康复机器人系统5.4.药房机器人系统5.5.非侵入性放射外科机器人系统6.医疗机器人市场分析,按应用分类6.1.引言6.2.腹腔镜6.3.神经外科6.4.配药6.5.骨科外科6.6.其他7.按地理位置划分的医疗机器人市场分析8.竞争情报8.1.竞争标杆与分析8.2.最近的投资和交易8.3.关键参与者的战略9.公司简介9.1.直觉外科公司股份有限公司9.2.史泰克公司9.3.HOCOM9.4。美敦力9.5.Auris Health,Inc.9.6。Accuray Inc.9.7.Omnicell,Inc.9.8.ARXIUM集团公司9.9。埃克索仿生欧洲有限公司9.10.Capsa Healthcare,LLC有关本报告的更多信息,请访问https://www.researchandmarkets.com/r/b84q1j。
Media Contact:
媒体联系人:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
研究和市场劳拉·伍德(Laura Wood),高级经理[受电子邮件保护]对于E.S.T办公时间,请拨打电话:+1-917-300-0470美国/加拿大免费电话:+1-800-526-8630对于格林尼治标准时间办公时间,请致电+353-1-416-8900美国传真:646-607-1907传真(美国境外):+353-1-481-1716
SOURCE Research and Markets
来源研究和市场
Related Links
相关链接
http://www.researchandmarkets.com
Http://www.researchandmarkets.com